Ken Stern & Associates’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$568K Hold
3,809
0.25% 56
2018
Q2
$587K Buy
3,809
+31
+0.8% +$4.68K 0.27% 46
2018
Q1
$525K Sell
3,778
-24
-0.6% -$3.52K 0.23% 48
2017
Q4
$521K Sell
3,802
-28
-0.7% -$3.7K 0.23% 56
2017
Q3
$500K Sell
3,830
-75
-2% -$10K 0.22% 54
2017
Q2
$520K Hold
3,905
0.24% 51
2017
Q1
$470K Sell
3,905
-32
-0.8% -$3.79K 0.22% 57
2016
Q4
$434K Sell
3,937
-31
-0.8% -$3.44K 0.22% 62
2016
Q3
$469K Hold
3,968
0.32% 44
2016
Q2
$444K Buy
3,968
+66
+2% +$7.1K 0.35% 45
2016
Q1
$393K Buy
3,902
+606
+18% +$58.1K 0.27% 51
2015
Q4
$350K Buy
3,296
+135
+4% +$13.9K 0.23% 60
2015
Q3
$295K Buy
+3,161
New +$327K 0.23% 56

Other funds holding LH

Ken Stern & Associates's LH Position: Q3 2018 in Review

Ken Stern & Associates held its Labcorp (LH) position steady in Q3 2018 at 3,809 shares worth $568K. The position accounts for 0.25% of the portfolio, ranked #56.

Ken Stern & Associates first reported a position in LH in Q3 2015 and has held it in 13 quarters since. The position peaked at $587K in Q2 2018. 793 funds tracked by Wall St. Rank hold LH as of Q3 2018.

  • Ken Stern & Associates held 3,809 shares of Labcorp worth $568K as of Q3 2018.
  • Ken Stern & Associates left its Labcorp share count unchanged in Q3 2018.
  • Labcorp made up 0.25% of Ken Stern & Associates's portfolio in Q3 2018, its #56 holding.
  • Ken Stern & Associates first reported a position in Labcorp in Q3 2015 and has held it in 13 quarters since.
  • Ken Stern & Associates's Labcorp position peaked at $587K in Q2 2018.
  • 793 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.